"Others in Trump administration pushing GLP-1s
Other Trump administration officials have stressed the importance of GLP-1 medications in reducing the chronic disease burden in the U.S.
Dr. Mehmet Oz, the Centers for Medicare and Medicaid Services administrator who serves under Kennedy, is one of the chief proponents of GLP-1 access in the Trump administration, and his agency has made inroads in expanding access to the medication.
Oz’s agency has been at the helm of negotiating most favored nation prescription drug pricing deals to lower prescription costs in the U.S. to levels comparable with other developed countries."
Framing: assertive ·
First seen: 2026-09-14 ·
Last seen: 2026-09-14 ·
Spread: 1 articles